CRISPR Therapeutics AG
NASDAQ:CRSP
Overview | Financials
Company Name | CRISPR Therapeutics AG |
Symbol | CRSP |
Currency | USD |
Price | 39.04 |
Market Cap | 3,332,200,640 |
Dividend Yield | 0% |
52-week-range | 36.52 - 91.1 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Samarth Kulkarni Ph.D. |
Website | https://www.crisprtx.com |
An error occurred while fetching data.
About CRISPR Therapeutics AG
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD